Yoseph Gurevich
Pediatric Gastroenterology · Babylon, NYNPI 1871932509
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations.
Across 129 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$663
- AbbVie$391
- Supernus Pharmaceuticals, Inc.$188
- Corium, LLC$161
- QOL Medical, LLC$158
- Ipsen Biopharmaceuticals, Inc$134
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,95599%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 21 | $663 |
| AbbVie | 11 | $391 |
| Supernus Pharmaceuticals, Inc. | 10 | $188 |
| Corium, LLC | 13 | $161 |
| QOL Medical, LLC | 5 | $158 |
| Ipsen Biopharmaceuticals, Inc | 6 | $134 |
| Acadia Pharmaceuticals Inc | 4 | $86 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
| Endo USA, Inc. | 4 | $81 |
| Biomarin Pharmaceutical Inc. | 3 | $79 |
| AstraZeneca | 4 | $78 |
| Baxter Healthcare | 4 | $67 |
| UCB, Inc. | 4 | $63 |
| Amphastar Pharmaceuticals, Inc. | 3 | $59 |
| Medtronic | 1 | $59 |
| Ironwood Pharmaceuticals, Inc | 3 | $57 |
| Pfizer | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Ironshore Pharmaceuticals Inc. | 3 | $44 |
| Global Blood Therapeutics, Inc. | 2 | $35 |
| Zealand Pharma US, Inc. | 1 | $29 |
| GSK | 2 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Mirum Pharmaceuticals, Inc. | 1 | $23 |
| Philips North America LLC | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Zogenix Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $22 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Neos Therapeutics, LP | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Sobi, Inc | 1 | $18 |
| Tolmar, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Greenwich Biosciences, Inc. | 1 | $14 |
| Neurelis, Inc. | 1 | $14 |
| Cognoa, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,978 in reported general payments places this provider in the 75th percentile of 143 pediatric gastroenterology providers in New York.
Other pediatric gastroenterology in Babylon
- David GoldBabylon$11K
- Sivan KinbergNew York$261K
- Tuvia MarcianoMineola$249K
- Mirna ChehadeNew York$217K
- Michael DolingerNew York$191K
- Thomas WallachNew York$160K
- Neal LeleikoNew York$157K
- Shari Sheflin FindlingNew Hyde Park$143K
- William TreemBrooklyn$118K
- Nanda KerkarRochester$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.